These minor structural differences differentially impact ApoE risk for AD, with ApoE4 identified as the strongest genetic risk factor for late-onset AD, conferring a 10–15-fold increased risk in homozygous carriers compared to neutral ApoE3 [14]. The gene discussed is APOE; the disease is Alzheimer disease.